How do I compare drug manufacturers general stocks?

Compare using valuation ratios (P/E, P/B, EV/EBITDA), profitability metrics, growth rates, and financial health indicators. Direct comparison within the same industry provides meaningful insights.

What to consider when investing in drug manufacturers general stocks?

Consider industry trends, competitive positioning, valuation relative to peers, financial strength, management quality, and dividend sustainability for income-focused investments.

Drug Manufacturers General Stocks - Companies, Performance & Financial Metrics

Q: How many stocks are in the drug manufacturers general industry?

There are 21 publicly traded stocks in the drug manufacturers general industry, part of the Healthcare sector.

Browse 21 drug manufacturers general stocks with financial metrics and performance data (Healthcare sector).

Drug Manufacturers General Stocks

21 stocks in the drug manufacturers general industry. Click column headers to sort.

#
1	LLY	Eli Lilly and Company	$1,185.87	$1.06T	$72.25B	$25.28B	$28.14	2.83M
2	JNJ	Johnson & Johnson	$259.27	$633.97B	$96.36B	$21.04B	$8.65	8.55M
3	AZN	AstraZeneca PLC	$168.27	$525.34B	$60.44B	$10.39B	$3.33	2.42M
4	ABBV	AbbVie Inc.	$256.92	$455.78B	$62.82B	$3.63B	$2.05	7.96M
5	MRK	Merck & Co., Inc.	$130.48	$322.55B	$65.69B	$8.94B	$3.58	10.62M
6	NVS	Novartis AG	$156.14	$299.16B	$56.58B	$13.53B	$6.99	2.07M
7	NVO	Novo Nordisk A/S	$48.18	$214.34B	$49.98B	$18.59B	$4.18	10.62M
8	AMGN	Amgen Inc.	$371.50	$202.10B	$37.22B	$7.80B	$14.38	2.76M
9	GILD	Gilead Sciences, Inc.	$130.86	$164.10B	$29.73B	$9.22B	$7.35	7.78M
10	PFE	Pfizer Inc.	$25.01	$143.33B	$63.31B	$7.49B	$1.31	47.03M
11	BMY	Bristol-Myers Squibb Company	$61.51	$125.91B	$48.48B	$7.28B	$3.57	12.01M
12	SNY	Sanofi	$43.36	$104.43B	$53.97B	$8.61B	$3.54	3.92M
13	GSK	GSK plc	$50.74	$103.36B	$43.73B	$7.78B	$4.34	3.96M
14	BIIB	Biogen Inc.	$200.62	$29.77B	$9.94B	$1.37B	$9.32	1.39M
15	GRFS	Grifols, S.A.	$7.54	$5.13B	$8.51B	$474.68M	$0.87	661.30K
16	OGN	Organon & Co.	$13.56	$3.56B	$6.16B	$246.00M	$0.94	2.53M
17	AMRN	Amarin Corporation plc	$13.60	$284.96M	$216.69M	-$33.61M	$-1.61	82.34K
18	SCLX	Scilex Holding Company	$7.39	$50.92M	$33.86M	-$377.66M	$-36.73	170.99K
19	MIRA	MIRA Pharmaceuticals, Inc.	$0.93	$38.92M	$0.00	-$9.81M	$-0.39	73.18K
20	NSRX	Nasus Pharma Ltd.	$3.09	$24.78M	—	-$5.86M	$-0.73	20.30K
21	MDCX	Medicus Pharma Ltd.	$0.38	$11.35M	$0.00	-$36.93M	$-1.69	1.64M

About the Drug Manufacturers General Industry

The Drug Manufacturers General industry comprises 21 publicly traded companies within the Healthcare sector that share similar business models and competitive dynamics.

Company Types

- Industry leaders with market share and scale
- Growth companies expanding rapidly
- Value opportunities below peer averages
- Dividend payers for income investors

Key Considerations

- Compare valuation ratios to industry peers
- Assess competitive positioning and moats
- Monitor regulatory and technology trends
- Evaluate financial health and cash flow